Kahsay Habte

Array ( [id] => 20420200 [patent_doc_number] => 20250382285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-12-18 [patent_title] => BICYCLIC-SUBSTITUTED GLUTARIMIDE CEREBLON BINDERS [patent_app_type] => utility [patent_app_number] => 19/303091 [patent_app_country] => US [patent_app_date] => 2025-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 106587 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 892 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19303091 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20517552 [patent_doc_number] => 20260041655 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-02-12 [patent_title] => PAPD5 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF TREATING NEUROLOGICAL AND COGNITIVE DISORDERS [patent_app_type] => utility [patent_app_number] => 19/296311 [patent_app_country] => US [patent_app_date] => 2025-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2679 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19296311 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20973504 [patent_doc_number] => 12734177 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-09-15 [patent_title] => Macrocyclic derivative and use thereof [patent_app_type] => utility [patent_app_number] => 19/198758 [patent_app_country] => US [patent_app_date] => 2025-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 26267 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19198758 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20136151 [patent_doc_number] => 20250243195 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-07-31 [patent_title] => FUSED IMIDAZOLE DERIVATIVE, PREPARATION METHOD THEREFOR, AND MEDICAL USE THEREOF [patent_app_type] => utility [patent_app_number] => 19/091638 [patent_app_country] => US [patent_app_date] => 2025-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29993 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19091638 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20372415 [patent_doc_number] => 12479837 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-11-25 [patent_title] => Reversible DPP1 inhibitors and uses thereof [patent_app_type] => utility [patent_app_number] => 19/088795 [patent_app_country] => US [patent_app_date] => 2025-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55374 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19088795 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20085063 [patent_doc_number] => 20250214999 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-07-03 [patent_title] => HETEROCYCLIC GLP-1 AGONISTS [patent_app_type] => utility [patent_app_number] => 19/083274 [patent_app_country] => US [patent_app_date] => 2025-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38729 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19083274 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20100235 [patent_doc_number] => 20250230171 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-07-17 [patent_title] => SEMI-SATURATED BICYCLIC DERIVATIVES AND RELATED USES [patent_app_type] => utility [patent_app_number] => 19/076644 [patent_app_country] => US [patent_app_date] => 2025-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 121805 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19076644 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20136155 [patent_doc_number] => 20250243199 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-07-31 [patent_title] => FUSED HETEROCYCLES AS 5-HT2A RECEPTOR AGONISTS [patent_app_type] => utility [patent_app_number] => 19/071155 [patent_app_country] => US [patent_app_date] => 2025-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20024 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19071155 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20328390 [patent_doc_number] => 12458647 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-11-04 [patent_title] => Macrocyclic derivative and use thereof [patent_app_type] => utility [patent_app_number] => 19/069098 [patent_app_country] => US [patent_app_date] => 2025-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 26189 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19069098 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20115980 [patent_doc_number] => 12365669 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-07-22 [patent_title] => THRb receptor agonist compound and preparation method and use thereof [patent_app_type] => utility [patent_app_number] => 19/052553 [patent_app_country] => US [patent_app_date] => 2025-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8073 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 204 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19052553 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20040832 [patent_doc_number] => 20250179054 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-06-05 [patent_title] => THRB RECEPTOR AGONIST COMPOUND AND PREPARATION METHOD AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 19/052557 [patent_app_country] => US [patent_app_date] => 2025-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8104 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 174 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19052557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20059203 [patent_doc_number] => 20250197425 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-06-19 [patent_title] => 2,6,9-TRISUBSTITUTED PURINES [patent_app_type] => utility [patent_app_number] => 19/038077 [patent_app_country] => US [patent_app_date] => 2025-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60002 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19038077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20033235 [patent_doc_number] => 20250171457 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-05-29 [patent_title] => NITROGEN-CONTAINING HETEROCYCLIC COMPOUND HAVING NRF2 ACTIVATION EFFECT [patent_app_type] => utility [patent_app_number] => 19/033289 [patent_app_country] => US [patent_app_date] => 2025-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 72981 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19033289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19983957 [patent_doc_number] => 20250122179 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-04-17 [patent_title] => BICYCLIC-SUBSTITUTED GLUTARIMIDE CEREBLON BINDERS [patent_app_type] => utility [patent_app_number] => 18/972557 [patent_app_country] => US [patent_app_date] => 2024-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 106574 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18972557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20158162 [patent_doc_number] => 12384773 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-08-12 [patent_title] => Thiazole compounds and methods of use thereof [patent_app_type] => utility [patent_app_number] => 18/934931 [patent_app_country] => US [patent_app_date] => 2024-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50022 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18934931 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19728823 [patent_doc_number] => 20250031574 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-23 [patent_title] => DONOR-ACCEPTOR TYPE THERMALLY ACTIVATED DELAYED FLUORESCENT MATERIALS BASED ON IMIDAZO[1,2-F]PHENANTHRIDINE AND ANALOGUES [patent_app_type] => utility [patent_app_number] => 18/888830 [patent_app_country] => US [patent_app_date] => 2024-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12571 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18888830 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19683950 [patent_doc_number] => 20250002495 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-02 [patent_title] => SPIRO-LACTAM NMDA MODULATORS AND METHODS OF USING SAME [patent_app_type] => utility [patent_app_number] => 18/885569 [patent_app_country] => US [patent_app_date] => 2024-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30580 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18885569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19683956 [patent_doc_number] => 20250002501 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-02 [patent_title] => INHIBITORS OF CYCLIC MONO- AND DI-NUCLEOTIDE PHOSPHODIESTERASES AND THE USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/885251 [patent_app_country] => US [patent_app_date] => 2024-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12422 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18885251 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19692766 [patent_doc_number] => 20250011311 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-09 [patent_title] => AMIDO HETEROAROMATIC COMPOUNDS [patent_app_type] => utility [patent_app_number] => 18/884381 [patent_app_country] => US [patent_app_date] => 2024-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38246 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18884381 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20949875 [patent_doc_number] => 20260256731 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-09-03 [patent_title] => RETINAL VASODILATOR AND PHARMACEUTICAL COMPOSITION [patent_app_type] => utility [patent_app_number] => 18/846479 [patent_app_country] => US [patent_app_date] => 2023-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1150 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18846479 [rel_patent_id] =>[rel_patent_doc_number] =>)